Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's Disease
Maureen J. Koslowski(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Jan Wehkamp(Robert Bosch Hospital), Eduard F. Stange(John Radcliffe Hospital), Klaus Fellermann(Apple (Israel)), Laurent Peyrin‐Biroulet(Délégation Centre-Est), Alexander Teml(Statistics Austria), Matthias Schwab(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Rachel Cooney(John Radcliffe Hospital), Elke Schaeffeler(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Irmgard Kübler(Robert Bosch Hospital), Mathias Chamaillard(Inserm), Julia Beisner(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Stefan Winter(St. Vincenz-Krankenhaus Limburg), Guoxing Wang(Capital Medical University), Paul Rutgeerts(KU Leuven), Derek P. Jewell(University of Oxford), Klaus Herrlinger(Robert Bosch Hospital), Charles Bevins(University of California, Davis), Walter Reinisch(Medical University of Vienna), Séverine Vermeire(KU Leuven)
Cited by 136
Related Papers
A roadmap for graphene
|Nature|2012|9.1k
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k